Guardian Pharmacy Services, Inc. (GRDN) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-43.2%

$22.58

vs $39.79 price

Levered DCF

$58.04

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

12.8

Safe zone

Rating

B+

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	38.09×	-11.45×	41.03×	27.59×	59.26×	48.48×	44.44×	66.67×
P/B	9.12×	8.81×	34.51×	22.78×	40.69×	25.3×	0×	28.61×
P/S	1.3×	1.02×	0.93×	1.07×	1.23×	1.32×	1.39×	1.62×
EV / EBITDA	19.17×	-29.51×	17.72×	15.2×	21.8×	20.91×	20.83×	26.5×
Gross margin	19.5%	19.9%	19.9%	20.4%	20.4%	20.0%	20.5%	20.5%
Operating margin	6.1%	-5.1%	3.9%	5.7%	3.8%	4.4%	4.9%	4.3%
Net margin	3.4%	-7.1%	2.3%	3.9%	2.1%	2.7%	3.1%	2.4%
Current ratio	1.38×	1.05×	0.94×	1.07×	1×	1.09×	1×	1.24×
Debt / equity	0.18×	0.21×	2.45×	1.47×	2.3×	1.53×	0×	1.28×
Interest coverage	133.71×	-19.19×	14.32×	26.99×	18.42×	14.87×	15.15×	13.65×
Dividend yield	0.0%	2.8%	3.9%	3.2%	1.8%	1.1%	3.5%	2.9%
Payout ratio	0.0%	-41.0%	160.7%	87.0%	106.4%	54.2%	157.8%	190.7%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	23.9%	-61.2%	84.7%	82.9%	68.2%	51.8%	0.0%	43.1%
Return on invested capital	22.9%	-34.3%	26.2%	32.4%	22.1%	22.3%	27.0%	21.3%
Return on assets	11.9%	-27.2%	8.8%	13.8%	6.9%	9.2%	11.1%	8.1%
Free cash flow yield	4.3%	3.3%	5.8%	3.3%	5.1%	4.5%	4.3%	3.5%
Earnings yield	2.6%	-6.9%	2.5%	3.6%	1.7%	2.0%	2.2%	1.5%
Enterprise value	$1.8B	$1.3B	$1B	$1B	$1B	$1B	$1B	$1B
Net debt / EBITDA	-0.3×	-0.59×	1.16×	0.92×	0.86×	1.07×	1.15×	1.08×
Cash conversion cycle (days)	3	6	6	9	7	9	13	14